DuPont 2014 Annual Report Download - page 100

Download and view the complete annual report

Please find page 100 of the 2014 DuPont annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 106

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106

E. I. du Pont de Nemours and Company
Notes to the Consolidated Financial Statements (continued)
(Dollars in millions, except per share)
F-47
21. SEGMENT INFORMATION
The company consists of 12 businesses which are aggregated into 7 reportable segments based on similar economic characteristics,
the nature of the products and production processes, end-use markets, channels of distribution and regulatory environment. The
company's reportable segments are Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health,
Performance Chemicals, Performance Materials and Safety & Protection. The company includes certain embryonic businesses
not included in the reportable segments, such as pre-commercial programs, and nonaligned businesses in Other.
Major products by segment include: Agriculture (corn hybrids and soybean varieties, herbicides, fungicides and insecticides);
Electronics & Communications (photopolymers and electronic materials); Industrial Biosciences (enzymes and bio-based
materials); Nutrition & Health (cultures, emulsifiers, texturants, natural sweeteners and soy-based food ingredients); Performance
Chemicals (fluorochemicals, fluoropolymers, specialty and industrial chemicals, and white pigments); Performance Materials
(engineering polymers, packaging and industrial polymers, films and elastomers); and Safety & Protection (nonwovens, aramids
and solid surfaces). The company operates globally in substantially all of its product lines.
In general, the accounting policies of the segments are the same as those described in Note 1. Exceptions are noted as follows and
are shown in the reconciliations below. Segment sales include transfers to another business segment. Products are transferred
between segments on a basis intended to reflect, as nearly as practicable, the market value of the products. Segment net assets
includes net working capital, net property, plant and equipment, and other noncurrent operating assets and liabilities of the segment.
Affiliate net assets (pro rata share) excludes borrowing and other long-term liabilities. Depreciation and amortization includes
depreciation on research and development facilities and amortization of other intangible assets, excluding write-down of assets.
Prior years' data have been reclassified to reflect the current organizational structure.
The earnings from the previous Pharmaceuticals segment are insignificant in 2014 and therefore the results are reported within
Other. Viton® fluoroelastomer products (Viton®) will be included in the Performance Chemicals separation and therefore the
results are reported within Performance Chemicals. Viton® was previously reported within Performance Materials.
Reclassifications of prior year data have been made to conform to current year classifications.
Segment pre-tax operating income (loss) (PTOI) is defined as income (loss) from continuing operations before income taxes
excluding non-operating pension and other postretirement employee benefit costs, exchange gains (losses), corporate expenses
and interest.